Logo

CTCs

RareCyte Moving Into Higher-Plex Spatial Proteomics
Premium

The firm believes its Orion system's combination of multiplexing, data quality, and throughput will help it carve out a space in an increasingly crowded market.

Angle Finalizes Plans for First Clinical CTC Test in Ovarian Cancer
Premium

The firm cited new study results confirming that an assay analyzing circulating tumor cells isolated by its Parsortix platform can discriminate malignant pelvic masses.

Plus Therapeutics, Biocept Ink Lab Services Agreement for ReSPECT-LM Trial

Biocept will test patients with its CNSide cerebrospinal fluid cell capture assay to evaluate responses to Plus' radiotherapy drug candidate.

BioMark Diagnostics, Icahn Mount Sinai to Develop Multiomic Lung Cancer Tests

The partners also aim to develop a test for determining lung cancer subtype and stage using circulating tumor cells and metabolomics.

Genetron Highlights New Minimal Residual Disease Data, Sets Plans for Solid Tumor Testing in China
Premium

The company shared new liver cancer data in a recent journal letter, demonstrating high performance for its tumor-informed approach.

Dec 21, 2021

Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium

Dec 9, 2021

Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests

Oct 7, 2021

Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights
Premium

Aug 18, 2021

Datar Cancer Genetics Expands Business from Treatment Monitoring to Dx and Screening
Premium

Jul 28, 2021

Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies

Jul 21, 2021

Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests

May 27, 2021

TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research
Premium

May 10, 2021

TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform

Mar 31, 2021

Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay
Premium

Mar 31, 2021

Startup MiCareo Targets Rare Cell Isolation Market With Flow Displacement Instrument
Premium

Mar 29, 2021

Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag

Mar 25, 2021

Startup Tethis Targets Early-Stage Breast Cancer Detection With CTC Sample Prep Platform
Premium

Mar 24, 2021

Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform

Mar 23, 2021

CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test

Mar 18, 2021

Scienion, Gilupi to Develop Circulating Tumor Cell Analysis Workflow

Mar 17, 2021

Metabolic Marker Helps Identify Lung Cancer-Linked Circulating Tumor Cells
Premium

Mar 3, 2021

Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy
Premium

Jan 21, 2021

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay
Premium

Dec 18, 2020

BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership

Dec 10, 2020

Menarini's CellSearch Shows CTCs' Potential to Predict Breast Cancer Prognosis, Treatment Response
Premium

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.